All amounts in EUR:
All amounts in EUR:
Marel achieved 15% revenue growth in 2015. Revenue was 819 million with 12.2% adjusted EBIT or 100 million compared with 49 million in 2014 (6.8%). Net profit for 2015 is 57 million compared with 12 million last year.
Cash flow and operational performance was strong leading to net debt/EBITDA at 1.05 at the end of the year compared with 2.08 at the end of 2014. Marel is entering the year 2016 with order book of 181 million compared with 175 million at the beginning of 2015.
Marel closed the acquisition of MPS on January 29, 2016. The purchase price is 382 million on a debt and cash-free basis. Preliminary numbers from MPS’ operation show revenue of 158 million in 2015 and EBITDA of 41 million. Orders received were strong and totaled 190 million and MPS enters 2016 with order book of 140 million.
Marel has finalized long term all senior financing of an approximately 670 million with final maturity in November 2020. The financing is at favorable terms in line with Marel´s financial strengths and current market conditions.
Initial interest terms are EURIBOR/LIBOR plus a margin of 275 basis points which will vary in line with Marel’s leverage ratio (Net debt/EBITDA) at the end of each quarter. Opening leverage post MPS acquisition is below 3x Net debt/EBITDA.
Marel’s earnings per share (EPS) in 2015 are 7.93 euro cents compared with 1.60 euro cents for 2014. The acquisition of MPS is expected to be highly accretive and will enhance EPS going forward.
The Board of Directors will propose to the 2016 Annual General Meeting that dividend of 1.58 euro cent per outstanding share will be paid for 2015, corresponding to 11.3 million or approximately 20% of net profit for the year.
Pro-forma revenue for combined Marel and MPS in 2015 is 977 million with estimated adjusted EBIT of 133 million. Pro-forma order book is around 320 million entering 2016 compared with 280 million at the beginning of the year 2015.
Management expects modest organic revenue and EBIT growth in 2016 compared with 2015 on pro-forma basis, before purchase price allocation in relation with the acquisition.
“2015 was a great year for Marel. We successfully concluded our two year refocusing program, rationalizing the product portfolio, optimizing our manufacturing footprint and streamlining the operation.
“We managed to engage even better with our customers while refocusing, resulting in a 15% increase in revenue with 100 million in operating profits in 2015 compared with 49 million in 2014.
“With the acquisition of MPS we further enhanced Marel’s position as a global leading provider of advanced systems and services to the poultry, meat and fish industries.
“In many ways we are now taking similar steps in the meat industry as were taken eight years ago in the poultry industry with the Stork acquisition, which stimulated organic growth and value creation for customers and shareholders.
“Parallel to the acquisition of MPS we secured long term stable financing for the whole company that will support operational and financial flexibility going forward. We appreciate the continued trust from the banks that are supporting Marel as the consolidator in the industry.
“MPS is concluding a great year just like Marel. Combined revenues last year were 977 million with adjusted EBIT of 133 million. After a period of strong growth, we expect modest organic growth in revenues and operating performance in 2016.”
* Before refocusing cost of €4.3m and acquisition cost of 3.3m in Q4 and before refocusing cost of €15.0m and acquisition cost of 3.3m for the full year 2015.
Read press release in full
Statements in this press release that are not based on historical facts are forward-looking statements. Although such statements are based on management’s current estimates and expectations, forward-looking statements are inherently uncertain.
We, therefore, caution the reader that there are a variety of factors that could cause business conditions and results to differ materially from what is contained in our forward-looking statements, and that we do not undertake to update any forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.